Cargando…
The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID-19: A Prospective, Randomized, Multicenter, Open-Label Study
Introduction Coronavirus disease 2019 (COVID-19) is a serious concern of the new era. Along with antiviral synthetic medications, there is a need to discover efficacious herbal antiviral medicines with minimum side effects in patients against COVID-19. This study aimed to assess the efficacy and saf...
Autores principales: | Abhyankar, Mahesh, Kadam, Dilip, Reddy, P. Raghavendra, Siddiqui, Mohammed Zaki, Ratheesh, M, Jagmag, Tariq, Tilwani, Jayesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085312/ https://www.ncbi.nlm.nih.gov/pubmed/37051002 http://dx.doi.org/10.7759/cureus.35881 |
Ejemplares similares
-
Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm
por: Ratheesh, M., et al.
Publicado: (2022) -
Mycobacteremia from Crushed Hydromorphone Tablet Injection
por: Banno, Joseph M, et al.
Publicado: (2017) -
Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation
por: Dubhashi, Siddharth, et al.
Publicado: (2023) -
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease
por: Kainuma, Mosaburo, et al.
Publicado: (2022) -
Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases
por: Bai, Xinfeng, et al.
Publicado: (2023)